Remove category press-releases
article thumbnail

What They Said – Reviewing the First 6-Months of FDA Communications

Eye on FDA

The number of press releases issued by FDA during the first six months of the year declined to 101 from the 125 issued by June 30 of last year, the lowest number at mid-year since 2017. In 2022, the agency issued 27 releases that involved the subject of COVID, 18 of which were during the first half of the year.

article thumbnail

How to Cite Videos, Podcasts, Apps, Media, and Blogs in a Publication or CV (AMA style 11th edition)

ALiEM - Pharm Pearls

The American Medical Association (AMA) Manual of Style released its 11th edition in 2020. Photographs, ECGs, Radiology Images These fall into the category of “other multimedia” in the AMA Manual of Style, and here is my best attempt to interpret this to clinical media. Oxford University Press, 2020. Video Title. Version number.

130
130
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What They Said 2021 – An Overview of FDA Press Statements

Eye on FDA

This year, however, not only was the agency putting out less, the number of releases this past year represents a somewhat inflated number. In prior years, the agency statements under a heading called “ FDA in Brief “ These are statements that differ in format and nature from a traditional press release.

article thumbnail

What They Said – A Look Back at FDA Press Releases First Half of 2020

Eye on FDA

During the first half of the year, FDA issued a record number of press releases and nearly two-thirds (64 percent) were about COVID-19. The first release related to the pandemic appeared on February 24 to inform us about what steps the agency would be taking with respect to foreign inspections.

article thumbnail

Express Scripts on the Road to Damascus?

Ramblings of a pharmacist

Today, a friend shared this press release from Express Scripts with me. And this press release is a great example of that, but it also shows something deeper that is wrong with the PBMs being the lords of pharmacy. There are a lot of oddly worded phrases in this press release, and that’s what caught my attention.

article thumbnail

Despite ban, Martin Shkreli can’t seem to kick the pharma habit

pharmaphorum

” That is certainly a departure from Shkreli’s earlier efforts to disrupt the healthcare category by inflating the price of critical HIV medication Daraprim by around 5,000% when he was chief executive at Turing Pharma. .”

article thumbnail

Top 20 Nutraceutical Companies Based on 2022 Segment Revenue 

PharmaShots

The business sells nutraceutical products under categories, including Children's Health Supplements, Skin, Hair & Nails Supplements, and Immune Supplements. General Health, Immune, Cardiovascular, Digestive, Personal Care, and Weight Management are among the categories under which the company operates. Revenue: $548.3M